Skip to content
Recall Observatory FDA recall evidence

Drug product

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

D-067-2013

November 05, 2012

Class II

Product summary

Firm
Boehringer Ingelheim Roxane Inc
Event
Event 63630
Status
Terminated
Classification
Class II
Quantity
8,381 bottles
Official record key
drug-enforcement:D-067-2013

Official wording

Reason: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Code information: Lot 201900 Expiration Date: JAN 2015

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product